Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Milan S. Geybels, Min Fang, Jonathan L. Wright, Xiaoyu Qu, Marina Bibikova, Brandy Klotzle, Jian-Bing Fan, Ziding Feng, Elaine A. Ostrander, Peter S. Nelson, Janet L. Stanford
Published Sep 15, 2017 · Vol. 8, No. 48 · pp. 84338-84348
Kun Zhou, Kevin W. Diebel, Jon Holy, Andrew Skildum, Evan Odean, Douglas A. Hicks, Brent Schotl, Juan E. Abrahante, Monique A. Spillman, Lynne T. Bemis
Published Sep 8, 2017 · Vol. 8, No. 56 · pp. 95377-95391
Robert J. Cardnell, Lerong Li, Triparna Sen, Rasha Bara, Pan Tong, Junya Fujimoto, Abbie S. Ireland, Matthew R. Guthrie, Sheila Bheddah, Upasana Banerjee, Nene N. Kalu, You-Hong Fan, Scott J. Dylla, Faye M. Johnson, Ignacio I. Wistuba, Trudy G. Oliver, John V. Heymach, Bonnie S. Glisson, Jing Wang, Lauren A. Byers
Published Sep 1, 2017 · Vol. 8, No. 43 · pp. 73419-73432